Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography



	Full Text (PDF)
	Alert me when this article is cited
	Alert me if a correction is posted
	Citation Map



	Email this article to a Colleague
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new issues of the journal
	Add to My Articles & Searches
	Download to citation manager



	Citing Articles via HighWire
	Citing Articles via Google Scholar



	Articles by Wolkin, A.
	Articles by Cancro, R.
	Search for Related Content



	PubMed Citation
	Articles by Wolkin, A.
	Articles by Cancro, R.

Am J Psychiatry 1985; 142:564-571
Copyright © 1985 by American Psychiatric Association

REGULAR ARTICLES

Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography

A Wolkin, J Jaeger, JD Brodie, AP Wolf, J Fowler, J Rotrosen, F Gomez-Mont and R Cancro

Local cerebral metabolic rates were determined by positron emission tomography and the deoxyglucose method in a group of 10 chronic schizophrenic subjects before and after somatic treatment and in eight normal subjects. Before treatment, schizophrenic subjects had markedly lower absolute metabolic activity than did normal controls in both frontal and temporal regions and a trend toward relative hyperactivity in the basal ganglia area. After treatment, their metabolic rates approached those seen in normal subjects in nearly all regions except frontal. Persistence of diminished frontal metabolism was manifested as significant relative hypofrontality. These findings suggest specific loci of aberrant cerebral functioning in chronic schizophrenia and the utility of positron emission tomography in characterizing these abnormalities.

This article has been cited by other articles:

G. Winterer, R. Coppola, T. E. Goldberg, M. F. Egan, D. W. Jones, C. E. Sanchez, and D. R. Weinberger
Prefrontal Broadband Noise, Working Memory, and Genetic Risk for Schizophrenia
Am J Psychiatry, March 1, 2004; 161(3): 490 - 500.
[Abstract] [Full Text] [PDF]

G D Honey, P C Fletcher, and E T Bullmore
Functional brain mapping of psychopathology
J. Neurol. Neurosurg. Psychiatry, April 1, 2002; 72(4): 432 - 439.
[Abstract] [Full Text] [PDF]

V. Menon, R. T. Anagnoson, G. H. Glover, and A. Pfefferbaum
Functional Magnetic Resonance Imaging Evidence for Disrupted Basal Ganglia Function in Schizophrenia
Am J Psychiatry, April 1, 2001; 158(4): 646 - 649.
[Abstract] [Full Text]

P. F. LIDDLE, C. J. LANE, and E. T.C. NGAN
Immediate effects of risperidone on cortico--striato--thalamic loops and the hippocampus
The British Journal of Psychiatry, November 1, 2000; 177(5): 402 - 407.
[Abstract] [Full Text] [PDF]

L. Shihabuddin, M. S. Buchsbaum, E. A. Hazlett, M. M. Haznedar, P. D. Harvey, A. Newman, D. B. Schnur, J. Spiegel-Cohen, T. Wei, J. Machac, et al.
Dorsal Striatal Size, Shape, and Metabolic Rate in Never-Medicated and Previously Medicated Schizophrenics Performing a Verbal Learning Task
Arch Gen Psychiatry, March 1, 1998; 55(3): 235 - 243.
[Abstract] [Full Text] [PDF]

Get information about faster international access.